GlassScriptPhysician profile
Wesley Bland
NPI 1255965810
$784.24
in general payments reported to CMS, 2019-2025
17 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $24.17 · 2023: $409 · 2024: $120 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $135.55 | 2023 | Vectris Surescan |
| Collegium Pharmaceutical, INC. | $92.60 | 2023 | Belbuca |
| Otsuka America Pharmaceutical, INC. | $91.19 | 2023-2024 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $76.91 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $63.43 | 2025 | Austedo Xr |
| Sunovion Pharmaceuticals INC. | $54.90 | 2021 | |
| Ucb, INC. | $47.12 | 2023-2024 | Briviact |
| Abbvie INC. | $27.58 | 2024 | |
| Lundbeck LLC | $25.32 | 2024 | Rexulti |
| Exact Sciences Corporation | $23.46 | 2025 | The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $23.25 | 2024 | Auvelity |
| Sk Life Science, INC. | $22.91 | 2023 | |
| Solventum Corporation | $22.80 | 2025 | Activ.A.C. |
| Neurocrine Biosciences, INC. | $22.24 | 2023 | Ingrezza |
| Sumitomo Pharma America, INC. | $22.19 | 2023 | Aptiom |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.61 | 2023 | Xarelto |
| Amgen INC. | $14.18 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Bland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.